Use of Liquid Biopsy in Monitoring Colorectal Cancer Progression Shows Strong Clinical Correlation

Monitoring CRC patients' molecular changes in response to treatment via CTCs and ctDNA can provide real-time information to disease changes. The study demonstrated that the emergence of secondary mutations were strongly associated to poorer survival after treatment.